These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 5312455)

  • 21. [Osmotic resistance of lymphocytes in lymphogranulomatosis].
    Simbirtseva GD; Petrasheva NI
    Lab Delo; 1976; (8):468-70. PubMed ID: 66397
    [No Abstract]   [Full Text] [Related]  

  • 22. [Osmotic stability of leukocytes in some diseases of children].
    Goncharuk GM
    Pediatr Akus Ginekol; 1967; 5():18-9. PubMed ID: 5611245
    [No Abstract]   [Full Text] [Related]  

  • 23. [Inhibitory effect of sera from patients with rheumatic diseases on EA-rosette formation].
    Nasonov EL; Aleksandrova EN; Sura VV; Ivanova MM; Zimin IuI
    Ter Arkh; 1983; 55(7):32-7. PubMed ID: 6604958
    [No Abstract]   [Full Text] [Related]  

  • 24. [Influence of heparin on osmotic resistance of erythrocytes in normal subjects and in patients with coronary arteriosclerosis].
    Babei E; Ungureanu E; Cristea E
    Stud Cercet Med Interna; 1970; 11(1):61-6. PubMed ID: 5455847
    [No Abstract]   [Full Text] [Related]  

  • 25. [Ceruloplasmin determination in rheumatic disorders].
    Hajzoková M; Cicvárek Z; Sitaj S
    Fysiatr Revmatol Vestn; 1972 Aug; 50(4):179-82. PubMed ID: 4538247
    [No Abstract]   [Full Text] [Related]  

  • 26. [Early diagnosis of rheumatic disease].
    Danieli G; Corvetta A; Gabrielli A
    Minerva Med; 1981 Dec; 72(50):3413-7. PubMed ID: 6976528
    [No Abstract]   [Full Text] [Related]  

  • 27. Erythrocyte osmotic fragility in patients receiving hyperthermia with and without chemotherapy.
    Whang-Peng J; Lees DE; Schuette WH; Smith R; Bull JM; DeVita VT
    Cancer Treat Rep; 1981; 65(11-12):1103-4. PubMed ID: 7296555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Method of recording and evaluating parameters of erythrocyte distribution by osmotic resistance].
    Khrennikov VIu; Deev AI
    Lab Delo; 1987; (3):187-90. PubMed ID: 2438459
    [No Abstract]   [Full Text] [Related]  

  • 29. Changes in osmotic resistance of leucocytes in mental illnesses.
    Erban L; Richtrová E
    Act Nerv Super (Praha); 1981 Jun; 23(2):102-5. PubMed ID: 7270020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Neopterin: new immunological marker of autoimmune rheumatic disease].
    Nasonov EL; Samsonov MIu; Tilz G; Fuchs D
    Klin Med (Mosk); 2000; 78(8):43-6. PubMed ID: 11019525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases.
    Cheema GS; Roschke V; Hilbert DM; Stohl W
    Arthritis Rheum; 2001 Jun; 44(6):1313-9. PubMed ID: 11407690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Osmotic resistance of leukocytes under the influence of iodipamide].
    Svoboda M; Fiala J
    Fortschr Geb Rontgenstr Nuklearmed; 1969 Jan; 110(1):121-3. PubMed ID: 5390072
    [No Abstract]   [Full Text] [Related]  

  • 33. [Increase in the osmotic resistance of erythrocytes due to propranolol].
    Sominskiĭ VN; Okun' KV
    Lab Delo; 1981; (9):525-7. PubMed ID: 6169935
    [No Abstract]   [Full Text] [Related]  

  • 34. Polymorphonuclear elastase-alpha1-proteinase inhibitor (elastase-alpha1 antitrypsin) in patients with rheumatic diseases: influence of disease activity.
    Beyeler C; Banks RE; Bird HA
    J Rheumatol; 2000 Jan; 27(1):15-9. PubMed ID: 10648012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Ceruloplasmin dynamics during various degrees of activity of the rheumatic process and non-specific polyarthritis].
    Mikunis RI; Lubovoĭ AF
    Vrach Delo; 1968 Jun; 6():22-5. PubMed ID: 5307381
    [No Abstract]   [Full Text] [Related]  

  • 36. [Analysis of so-called rheumatic and pseudorheumatic complaints in patients in general practice].
    Brühl W; Amatuni H; Chwalińska-Sadowska H; Jarczyk E; Pyszkowska M
    Reumatologia; 1971; 9(1):41-58. PubMed ID: 5314151
    [No Abstract]   [Full Text] [Related]  

  • 37. Erythrocyte sedimentation rate within rheumatic disease clinics.
    Giacomello A; Quaratino CP; Zoppini A
    J Rheumatol; 1997 Nov; 24(11):2263-5. PubMed ID: 9375897
    [No Abstract]   [Full Text] [Related]  

  • 38. Prevalence of rheumatic diseases in Greece: a cross-sectional population based epidemiological study. The ESORDIG Study.
    Andrianakos A; Trontzas P; Christoyannis F; Dantis P; Voudouris C; Georgountzos A; Kaziolas G; Vafiadou E; Pantelidou K; Karamitsos D; Kontelis L; Krachtis P; Nikolia Z; Kaskani E; Tavaniotou E; Antoniades C; Karanikolas G; Kontoyanni A;
    J Rheumatol; 2003 Jul; 30(7):1589-601. PubMed ID: 12858464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on the acid polysaccharide of the white cells in rheumatic and other diseases showing its similarity to the acid polysaccharide of amyloid.
    BASSIOUNI M
    Ann Rheum Dis; 1955 Sep; 14(3):288-92. PubMed ID: 13259404
    [No Abstract]   [Full Text] [Related]  

  • 40. [Glycosaminoglycan inclusion bodies in leukocytes in patients with inflammatory rheumatic diseases].
    Suschke J; Müller-Fassbender H; Schattenkirchner M; Reiter W; Kunze D; Weber T
    MMW Munch Med Wochenschr; 1980 Apr; 122(16):595-6. PubMed ID: 6248773
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.